Stemson Therapeutics procures $15m Series A

Stemson Therapeutics, a San Diego-based pre-clinical stage cell therapy company, has raised $15 million in Series A funding.

Stemson Therapeutics, a San Diego-based pre-clinical stage cell therapy company, has raised $15 million in Series A funding. DCVC Bio led the round with participation from other backers that included Genoa Ventures and AbbVie Ventures.

Source: Press Release